evans blue has been researched along with Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Li, J; Lv, C; Tan, W; Yang, C | 1 |
| Buck, AK; Hänscheid, H; Hartrampf, PE; Lapa, C; Schirbel, A | 1 |
| Anderson-Haley, M; Garcia, R; Hughes, SD; Nelson, A; Sivakumar, PV; Waggie, KS | 1 |
| Ali, IU; Chen, X; Huang, P; Jacobson, O; Kiesewetter, DO; Lang, L; Niu, G; Teng, G; Wang, Y; Wang, Z | 1 |
| Giraudo, E; Maione, F | 1 |
| Buller, HR; Esmon, CT; Niers, TM; Richel, DJ; Spek, CA; Tigchelaar, W; Van Noorden, CJ; Van Sluis, GL | 1 |
| Lewis, JD; Parseghian, MH; Pink, DB; Schulte, W; Zijlstra, A | 1 |
| LANDSBERGER, A | 1 |
| SWEET, WH | 1 |
| Baxter, LT; Boucher, Y; Brekken, C; Jain, RK; Netti, PA | 1 |
| Ghussen, F; Isselhard, W; Müller, EW; Stock, W; Sturz, J; Welte, CP | 1 |
11 other study(ies) available for evans blue and Neoplasms
| Article | Year |
|---|---|
Improving Tumor Accumulation of Aptamers by Prolonged Blood Circulation.
Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Evans Blue; Half-Life; Humans; Mice; Mice, Nude; Neoplasms; Optical Imaging; Serum Albumin; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |
Intraindividual comparison of [
Topics: Evans Blue; Humans; Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Somatostatin | 2021 |
Comparison of vascular leak syndrome in mice treated with IL21 or IL2.
Topics: Analysis of Variance; Animals; Capillary Leak Syndrome; Cytokines; Dose-Response Relationship, Drug; Evans Blue; Humans; Immunophenotyping; Immunotherapy; Interleukin-2; Interleukins; Liver; Lung; Mice; Neoplasms; Recombinant Proteins | 2013 |
In vivo albumin labeling and lymphatic imaging.
Topics: Albumins; Aluminum Compounds; Animals; Diagnostic Imaging; Evans Blue; Fluorescence; Fluorides; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Hindlimb; Image Processing, Computer-Assisted; Inflammation; Luminescent Measurements; Lymph Nodes; Lymphatic Vessels; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Staining and Labeling | 2015 |
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.
Topics: Animals; Biological Availability; Blood Vessels; Cell Hypoxia; Cryopreservation; Disease Models, Animal; Doxorubicin; Evans Blue; Fluorescent Antibody Technique; Fluorescent Dyes; Lectins; Mice; Microvessels; Neoplasms; Neovascularization, Pathologic; Pericytes; Permeability | 2015 |
Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement.
Topics: Animals; Antibodies, Monoclonal; Anticoagulants; Antigens, CD; Cadherins; Endothelium, Vascular; Evans Blue; Female; Melanoma, Experimental; Mice; Models, Biological; Neoplasms; Oxadiazoles; Protein C; Receptors, Lysosphingolipid; Signal Transduction; Thiophenes | 2009 |
Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery.
Topics: Animals; Capillary Permeability; Cell Line; Chick Embryo; Chorioallantoic Membrane; Doxorubicin; Drug Delivery Systems; Evans Blue; Humans; Interleukin-2; Microscopy; Neoplasms; Neovascularization, Pathologic; Time-Lapse Imaging; Transplantation, Heterologous; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2012 |
[Selective penetration of Evans blue in tumor cells with heparinoid].
Topics: Coloring Agents; Evans Blue; Heparinoids; Humans; Neoplasms; Neoplasms, Experimental | 1963 |
Failure to demonstrate gliomas with Evans blue; precautions in use of intravital dyes in man.
Topics: Brain Neoplasms; Coloring Agents; Evans Blue; Glioma; Humans; Male; Neoplasms; Staining and Labeling | 1950 |
Intratumoral infusion of fluid: estimation of hydraulic conductivity and implications for the delivery of therapeutic agents.
Topics: Absorption; Animals; Coloring Agents; Evans Blue; Extracellular Space; Humans; Injections, Intralesional; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Pharmacokinetics; Tumor Cells, Cultured | 1998 |
[Dye dilution test to determine leakage during regional perfusion in the treatment of malignant tumors of the extremities].
Topics: Animals; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Dogs; Dye Dilution Technique; Evans Blue; Extremities; Neoplasms | 1979 |